Martínez-Martínez, L, Lacruz, AC, Querol, L, Cortés-Vicente, E, Pascual, E, Rojas-García, R, Reyes-Leiva, D, Alvaro, Y, Moltó, E, Ortiz, E, Gallardo, E, Juárez, C, Mariscal, A. Inter-laboratory comparison of routine autoantibody detection methods for autoimmune neuropathies and myasthenia gravis. JOURNAL OF NEUROLOGY. 2024; 271(7)DOI:10.1007/s00415-024-12317-0. PMID:38578496. IF:4.600(Q1/2D).

Cortés-Vicente, E, Schreiner, B, Saccà, F, Narayanaswami, P. Editorial: New perspectives in the treatment of myasthenia gravis. Frontiers in Neurology. 2024; 15DOI:10.3389/fneur.2024.1418631. PMID:38919972. IF:2.800(Q2/5D).

Saccà, F, Salort-Campana, E, Jacob, S, Cortés-Vicente, E, Schneider-Gold, C. Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy. EUROPEAN JOURNAL OF NEUROLOGY. 2024; 31(6)DOI:10.1111/ene.16180. PMID:38117543. IF:3.900(Q1/3D).

Tawil, R, Wagner, KR, Hamel, J, Leung, DG, Statland, JM, Wang, LH, Genge, A, Sacconi, S, Lochmüller, H, Reyes-Leiva, D, Diaz-Manera, J, Alonso-Perez, J, Muelas, N, Vilchez, JJ, Pestronk, A, Gibson, S, Goyal, NA, Hayward, LJ, Johnson, N, LoRusso, S, Freimer, M, Shieh, PB, Subramony, SH, van Engelen, B, Kools, J, Leinhard, OD, Widholm, P, Morabito, C, Moxham, CM, Cadavid, D, Mellion, ML, Odueyungbo, A, Tracewell, WG, Accorsi, A, Ronco, L, Gould, RJ, Shoskes, J, Rojas, LA, Jiang, JG. Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial. LANCET NEUROLOGY. 2024; 23(5)DOI:10.1016/S1474-4422(24)00073-5. PMID:38631764. IF:45.500(Q1/1D).

Piñol-Jurado, P, Verdú-Díaz, J, Fernández-Simón, E, Domínguez-González, C, Hernández-Lain, A, Lawless, C, Vincent, A, González-Chamorro, A, Villalobos, E, Monceau, A, Laidler, Z, Mehra, P, Clark, J, Filby, A, Mcdonald, D, Rushton, P, Bowey, A, Perez, JA, Tasca, G, Marini-Bettolo, C, Guglieri, M, Straub, V, Suarez-Calvet, X, Diaz-Manera, J. Imaging mass cytometry analysis of Becker muscular dystrophy muscle samples reveals different stages of muscle degeneration. Scientific Reports. 2024; 14(1)DOI:10.1038/s41598-024-51906-x. PMID:38336890. IF:3.900(Q1/2D).

Pascual-Goñi, E, Collet, R, Tejada-Illa, C, Martín-Aguilar, L, Caballero-Avila, M, Lleixà, C, Novelli, S, López-Pardo, J, Sanfeliu, AE, Mariscal, A, Gargallo, YA, Martínez-Hernández, E, Cocho, D, Querol, L. Excellent response to anti-CD38 therapy with daratumumab in a patient with severe refractory CANOMAD. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2024; 95(7)DOI:10.1136/jnnp-2023-332443. PMID:38341197. IF:7.500(Q1/1D).

Bolano-Diaz, C, Verdú-Díaz, J, Gonzalez-Chamorro, A, Fitzsimmons, S, Veeranki, G, Straub, V, Diaz-Manera, J. Magnetic resonance imaging-based criteria to differentiate dysferlinopathy from other genetic muscle diseases. NEUROMUSCULAR DISORDERS. 2024; 34DOI:10.1016/j.nmd.2023.11.004. PMID:38007344. IF:2.800(Q2/5D).

Esteller D., Schiava M., Verdú-Díaz J., Villar-Quiles R.-N., Dibowski B., Venturelli N., Laforet P., Alonso-Pérez J., Olive M., Domínguez-González C., Paradas C., Vélez B., Kostera-Pruszczyk A., Kierdaszuk B., Rodolico C., Claeys K., Pál E., Malfatti E., Souvannanorath S., Alonso-Jiménez A., de Ridder W., De Smet E., Papadimas G., Papadopoulos C., Xirou S., Luo S., Muelas N., Vilchez J.J., Ramos-Fransi A., Monforte M., Tasca G., Udd B., Palmio J., Sri S., Krause S., Schoser B., Fernández-Torrón R., López de Munain A., Pegoraro E., Farrugia M.E., Vorgerd M., Manousakis G., Chanson J.B., Nadaj-Pakleza A., Cetin H., Badrising U., Warman-Chardon J., Bevilacqua J., Earle N., Campero M., Díaz J., Ikenaga C., Lloyd T.E., Nishino I., Nishimori Y., Saito Y., Oya Y., Takahashi Y., Nishikawa A., Sasaki R., Marini-Bettolo C., Guglieri M., Straub V., Stojkovic T., Carlier R.Y., Díaz-Manera J.. Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis (Journal of Neurology, (2023), 270, 12, (5849-5865), 10.1007/s00415-023-11862-4). JOURNAL OF NEUROLOGY. 2024; 271(4)DOI:10.1007/s00415-023-12178-z. PMID:38349561. IF:4.600(Q1/2D).